Sorry, this Apartment for sale in Villette, 5th Settlement Compounds is no longer available
However we have hundreds of similar properties for you
View similar properties


APARTMENT FOR SALE IN VILLETTE, 5TH SETTLEMENT COMPOUNDS
SODIC Villette – Sky Condos
Apartment for Sale
A well-positioned 169 sqm apartment in Sky Condos, one of the premium residential phases within SODIC Villette in New Cairo. The apartment offers a practical layout with 3 bedrooms and 3 bathrooms, making it suitable for both comfortable family living and investment.
BUA: 169 sqm
3 Bedrooms
3 Bathrooms
Semi Finished
The apartment is located within Villette, a high-end SODIC community known for its contemporary architecture, landscaped surroundings, green open spaces, and well-planned residential neighborhoods. Residents also benefit from access to a range of lifestyle facilities and amenities within the community, with convenient access to major roads and key destinations in New Cairo.
Down Payment: 12,000,000 EGP
Remaining: 2,500,000 EGP
Total: 14,500,000 EGP
Property details
Listed
1 month ago
Property Type
Apartment
Bedrooms
3 Beds
Bathrooms
3 Baths
Area
169 sqm
Price per area
85,798 EGP/sqm
Available from
23 Sep 2026
Amenities
Building / Compound Specific
Clubhouse
Apartment for Sale
A well-positioned 169 sqm apartment in Sky Condos, one of the premium residential phases within SODIC Villette in New Cairo. The apartment offers a practical layout with 3 bedrooms and 3 bathrooms, making it suitable for both comfortable family living and investment.
BUA: 169 sqm
3 Bedrooms
3 Bathrooms
Semi Finished
The apartment is located within Villette, a high-end SODIC community known for its contemporary architecture, landscaped surroundings, green open spaces, and well-planned residential neighborhoods. Residents also benefit from access to a range of lifestyle facilities and amenities within the community, with convenient access to major roads and key destinations in New Cairo.
Down Payment: 12,000,000 EGP
Remaining: 2,500,000 EGP
Total: 14,500,000 EGP
Regulatory information
Regulatory information
Reference
MDAFD9Z8JB69ZS1YE3E77V1XV8